COVID-19 Prevention and Management: Caring for Your Rheumatology Patients

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Activity Description

COVID-19 has led to a healthcare crisis that continues to have significant morbidity and mortality for vulnerable populations. Immune-mediated inflammatory diseases (IMIDs) and immunosuppressive therapies create a heterogeneous group of immunosuppressed patients at increased risk for poor vaccine response, high symptomatic burden, and progression to severe COVID-19. Disease prevention, rapid diagnosis, and timely initiation of treatment is therefore of great importance for rheumatology patients. In this fast-paced educational program, faculty will review the latest data, therapies, and strategies to educate patients and practitioners on the prevention and outpatient management of COVID-19 in patients with IMIDs. This CE activity will feature interactive Rapid-Fire Roundtable discussions and case presentations, in which experts in rheumatology, immunology, and infectious diseases discuss current challenges and opportunities regarding COVID-19 prevention and management.

Target Audience

The intended audience for this activity is rheumatologists and other healthcare professionals involved in the management of patients who are immunocompromised.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Identify patients with inflammatory rheumatic diseases who are at high-risk for severe COVID-19 outcomes.
• Summarize current and emerging strategies for the prevention of COVID-19 in immunocompromised patients with IMIDs.
• Outline approaches to improve care coordination for immunocompromised patients at-risk for severe COVID-19 outcomes.

Activity Chair

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH

Faculty

Cassandra Calabrese, DO
Assistant Professor of Medicine
Rheumatology and Infectious Disease
Cleveland Clinic Foundation
Cleveland, OH

Alfred Kim, MD, PhD
Associate Professor, Medicine
Associate Professor, Pathology & Immunology
Director, Lupus Center
Washington University School of Medicine
St. Louis, MO

Kevin L. Winthrop, MD, MPH
Professor, Division of Infectious Diseases
Schools of Medicine and Public Health
Oregon Health and Sciences University
Portland, OR

Jinoos Yazdany, MD, MPH
Professor of Medicine
University of California San Francisco
San Francisco, CA

Planner/Reviewer

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, January 3, 2024, to January 2, 2025.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Cassandra Calabrese, DO
Consultant: AstraZeneca, Pfizer
Speaker Contracted by Ineligible Company: AstraZeneca

Leonard H. Calabrese, DO
Consultant: AbbVie, AstraZeneca, GSK, Janssen, Regeneron
Speaker Contracted by Ineligible Company: AstraZeneca, Janssen, Regeneron

Alfred Kim, MD, PhD
Consultant: AstraZeneca, GlaxoSmithKline, Pfizer
Speaker Contracted by Ineligible Company: GlaxoSmithKline
Independent Research Contractor: GlaxoSmithKline

Kevin L. Winthrop, MD, MPH
Consultant: AbbVie, AstraZeneca, Gilead, GSK, Pfizer, Regeneron, Roche
Independent Research Contractor: Pfizer

Jinoos Yazdany, MD, MPH
Consultant: AstraZeneca, Pfizer
Independent Research Contractor: AstraZeneca, Gilead

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by getting in touch with our designated copyright agent (as outlined below). To do so, kindly provide the following details:

• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (e.g., URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you either are the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:

Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com